7Baggers
 bioatla (nasdaq:bcab) stock price up 3.3% – time to buy?  Defense World Tue, 30 Sep 2025 06:27:59 GMT
 BioAtla Granted Continued Nasdaq Listing with Conditions  The Globe and Mail Tue, 23 Sep 2025 20:46:00 GMT
 BioAtla Granted Continued Nasdaq Listing with Conditions  TipRanks Mon, 22 Sep 2025 07:00:00 GMT
 citizens jmp maintains bioatla(bcab.us) with hold rating  富途牛牛 Tue, 09 Sep 2025 07:00:00 GMT
 bioatla (nasdaq:bcab) raised to sell at wall street zen  Defense World Mon, 08 Sep 2025 14:01:45 GMT
 fda aligns with bioatla on phase 3 trial design for cancer drug  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 what bioatla inc (nasdaq: bcab) stock didn’t tell you this week  stocksregister.com Thu, 04 Sep 2025 14:40:00 GMT

BioAtla, Inc
(NASDAQ:BCAB) 

BCAB stock logo

BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of various cancers. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small c...

Founded: 2007
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends